跳至主要内容
临床试验/KCT0001603
KCT0001603尚未招募未知

Dose clinical dosage of dexamethasone inhibits the effect of sugammadex in reversing rocuronium?

Bundang CHA General Hospital0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 60(Year)(—)
性别
All

入选标准

  • Patients undergoing laryngeal microscopic surgery or nasal bone reduction operation under general anesthesia
  • American Society of Anesthesiologists (ASA) physical status classification system of I-II
  • Aged 20-60 years

排除标准

  • Difficult intubation was anticipated
  • If patients had a neuromuscular disorder that could impair neuromuscular block
  • Significant renal or hepatic dysfunction
  • A (family) history of malignant hyperthermia
  • Allergy to narcotics,neuromuscular blocking agents, or other medication used during general anesthesia
  • Receiving medications expected to interfere with the neuromuscular blocking agents

研究者

发起方
Bundang CHA General Hospital

相似试验

Dose clinical dosage of dexamethasone inhibits the... | 临床试验